• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Immunol . Targeting of neutrophil activation in the early phase of the disease for prevention of Coronavirus disease-19 severity

tetano

Editor, Senior Moderator
Microbiol Immunol


. 2022 Mar 29.
doi: 10.1111/1348-0421.12978. Online ahead of print.
Targeting of neutrophil activation in the early phase of the disease for prevention of Coronavirus disease-19 severity


Fujiro Sendo[SUP] 1 [/SUP], Hiroshi Yoshitake[SUP] 2 [/SUP], Yoshihiko Araki[SUP] 2 3 [/SUP]



Affiliations

Abstract

Prevention of the disease severity seems critical for mortality reduction of Coronavirus (CoV) disease-19. The neutrophils play a key role in the induction of severity. We here propose inhibition of neutrophil activation and/or cascade reactions of complement leading to this cell activation at the early phase of the disease as a potential tool to inhibit aggravation of the disease. We emphasize the need of appropriate timing for intervention as follows. 1) The intervention at the very early stage of severe acute respiratory syndrome-CoV-2 infection may harm the defensive host response to the infection because of a critical function of neutrophils in this response, and 2) intervention at too late a stage will not stop the infiltration of fully activated neutrophils that produce large amounts of toxic substances. This article is protected by copyright. All rights reserved.

Keywords: ARDS; COVID-19; GPI-80; Infection immunity; neutrophil.
 
Back
Top Bottom